UAE’s rapid infrastructural development, growing focus on preventive care, advancements in patient care delivery and Government support will positively transform the market.

Effect of Technology & Digital Health: UAE’s health regulators are increasingly considering the adoption of new smart technologies. The country is predicted to add an additional AED 668.4 Bn to its economy by 2035 on the back of accelerated AI adoption. Smart medi tech breakthroughs in the AED 39.3 Bn diabetes monitoring market, will transform life for 1.2 Mn people in the UAE. Innovations include insulin delivery systems, glucometers and other areas specifically targeted to address the many complications that arise from the disease.

Telehealth Services: Telehealth services are being promoted all over the globe for their quick response & ability to help the patients in times of emergency. Digital health solutions around telehealth covering remote consultations were introduced in UAE in 2019, where select private healthcare operators across the country started offering telehealth services to patients. Telehealth will help the patients in emergencies though medications for diabetes treatment such as insulin are taken by many with the help of health care providers. Not only this, individuals who reside away from hospitals & clinics can be assured of timely checkup via telehealth services which can curtail unpredictability to a large extent.

Rising Cost of Treatments: Diabetes treatment is unaffordable for non- residents in UAE due to income inequality in the economy in the remote or rural regions such as Al Khari, Labsah, Masafi and more. This creates an environment of uncertainty & anxiousness for individuals who are not well off. Not only this, there is minimal diabetes care services access for many people in the country, due to poor concentration of clinics in sub-urban and rural areas in comparison to urban provinces. This can be solved by setting up clinics and services in rural areas especially with the help of Government & increasing the concentration of private clinics in rural areas owing to low cost of operation.

Visit @ https://www.kenresearch.com/healthcare/general-healthcare/uae-diabetes-care-services-market-outlook-to-2027/596243-91.html

Decision Making parameters: Convenience plays a greater role in deciding a clinic or hospital. A patient will be far more likely to visit a clinic that is in a convenient location as compared to the one far away from his/her existing location. Lower neighborhood level access can result in health care decisions that might reduce continuity of diabetes care. Primary care treatment clinics will be preferred by customers as they provide greater consumer proximity. When it comes to insurance services, Abu Dhabi and Dubai Government provides full medical coverage for all UAE nationals which is a major factor influencing the hospital visits. Insurance premium ranges around AED 5,500 a year and expats who have health cards from the Government can avail concessions in treatment and opt for health care services. This helps to increase the level of trust an individual has in the healthcare services thereby reducing uncertainty faced by them.

Analysts at Ken Research in their latest publication “UAE Diabetes Care Service Market Outlook to 2027F - Driven by Rising Diabetes Cases and Increasing Privatization in the Healthcare sector” by Ken Research observed that UAE Diabetes Care Services market is in the growing phase, growing at CAGR of 5.9% between FY’17-FY’22P owning to the favorable government Initiatives, increase in diabetes patient and rising technological advancement. It is expected that UAE Diabetes Care Services market will continue to grow, at a CAGR of 6.1% for the FY’22P- FY’27F forecasted period.

Key Segments Covered

UAE Diabetes Care Services Market:

By Types of Services, FY’2022P & FY’2027F:
Injectables
Oral Drugs
Combination
Lifestyle Changes
By Type of Requirement, FY’2022P & FY’2027F:
Tertiary Care
Secondary Care
Primary Care

Request for Sample Report @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MjQz

By Revenue Division, FY’2022P & FY’2027F:
Domestic
International
By End-User, FY’2022p & FY’2027F:
Diabetes Clinics
Hospitals
By Diabetes Clinics, FY’2022P & FY’2027F:
Organized
Unorganized

Key Target Audience

Hospitals
Diabetic Care Service Provider
Diabetic Care Equipment Distributer
Diabetic Care Equipment Manufacturer
Clinics
Market Research and Consulting Firms
Healthcare Companies
Pharmaceutical Companies
Tourism Agencies
Government Bodies & Regulating Authorities
New Entrants

Time Period Captured in the Report:

Historical Period: FY’17- FY’22P
Base Year: FY’22P
Forecast Period: FY’22P – FY’27F

Learn more about report @ https://www.kenresearch.com/healthcare/general-healthcare/uae-diabetes-care-services-market-outlook-to-2027/596243-91.html

Companies Covered:

Imperial College London Diabetes Centre
Glucare Health
Mediclinic Middle East
Cleveland Clinic
NMC Healthcare

Key Topics Covered in the Report:

Executive Summary of UAE Diabetes Care Services Market
Market Size of UAE Diabetes Care Services Market
Market Segmentation of UAE Diabetes Care Services Market
SWOT Analysis of UAE Diabetes Care Services Market
Trends and Developments in UAE Diabetes Care Services Market
Factors considered by Hospitals and clinics for Treatment
Regulatory Bodies of UAE Diabetes Care Services Market
Overview of Emirates Diabetes Endocrine Society
Challenges and restrains in UAE Diabetes Care Services Market
End User Analysis of UAE Diabetes Care Services Market
Competitive Analysis of UAE Diabetes Care Services Market (Inception, USP, Insurance Partner, No of Clinics, Clinics by region, est. revenue, no of doctors, no of employees, no of walk-in per day per clinic, major treatment offered)
Future Outlook of UAE Diabetes Care Services Market
Covid Analysis of UAE Diabetes Care Services Market
Analyst Recommendations

For more information on the research report, refer to below link:

https://www.kenresearch.com/healthcare/general-healthcare/uae-diabetes-care-services-market-outlook-to-2027/596243-91.html

Related Reports:

https://www.kenresearch.com/healthcare/medical-devices/diabetes-care-device/595676-91.html

https://www.kenresearch.com/healthcare/general-healthcare/type-diabetes-therapeutics/592851-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/diabetes-insulin-delivery/594171-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/type-diabetes-drugs/575713-91.html